Best Contract Management Software for Pharma and Life Sciences in India (2026)

A pharma or life-sciences company in India signs some of the most specialised contracts in any industry. Clinical-trial and CRO agreements, confidential disclosure agreements, material transfer agreements, quality and technical agreements, manufacturing and supply contracts, and IP and licensing deals all carry heavy regulatory and liability weight. The New Drugs and Clinical Trials Rules 2019 and the Central Drugs Standard Control Organisation shape trial and approval obligations, drug pricing runs through the DPCO framework, and quality agreements have to map to GMP responsibilities. A single mismatched indemnity, pharmacovigilance clause or data-ownership term can create real exposure. The right contract software keeps this complex paper correct and traceable. This roundup compares the tools that fit a pharma or life-sciences team, with honest strengths and the kind of organisation each one suits. ## The contract problems pharma and life-sciences teams in India actually face - Clinical and research paper. CRO agreements, site contracts, CDAs and MTAs with precise confidentiality, IP-ownership, publication and indemnity terms, framed by the New Drugs and Clinical Trials Rules 2019 and CDSCO oversight.

• Quality and supply. Quality or technical agreements that allocate GMP responsibilities, and manufacturing and supply contracts with recall, liability and compliance clauses.
• Regulatory and pricing overlay. CDSCO approvals and the DPCO pricing framework shape commercial terms and obligations.
• Pharmacovigilance and data. Safety-reporting duties and data-ownership terms that must be unambiguous across partners. ## What a pharma or life-sciences company should look for - Precise, structured drafting so specialised clauses stay internally consistent.
• Risk flagging on indemnity, IP-ownership, confidentiality and liability.
• Obligation tracking for regulatory and quality commitments with dates.
• Clean, auditable version history for inspections and partner disputes.
• India-law fluency alongside the ability to handle cross-border partners. ## The best contract management software for pharma and life sciences in India ### Adira Adira is an AI legal operating system built on Anthropic's Claude and India-first, suited to complex, clause-heavy contracts. Because the AI Drafting Studio produces a structured clause tree rather than flat text, dependencies between confidentiality, IP and indemnity clauses stay visible and precise edits are clean, which matters in CRO, CDA and MTA paper. Company Persona tunes drafts to your standard positions on IP ownership and liability. The Document Intelligence Dashboard grades each position favourable, neutral or unfavourable, surfaces red flags and obligations with dates, and flags missing clauses, which helps catch a weak indemnity or an absent publication term before signature. Pricing is public: the Practice plan is 89 US dollars per seat per month billed annually (minimum 3 seats), the Firm plan is 179 US dollars per seat per month billed annually (minimum 5 seats), Enterprise is custom, and there is a 7-day free trial. Adira does not train on your corpus, which matters for confidential research paper. In its own measured work across 18 law firms, review fell from 10 to 12 days to under 2 hours with 2 to 3 rechecks; those are Adira's results. The Command Centre dashboard is on the roadmap. Who it suits: pharma and life-sciences teams that want precise India-law drafting and per-clause risk review on specialised agreements. ### Sirion Sirion is an enterprise-grade CLM, India-founded and global, strong in post-signature obligation and performance management. For a large pharma company tracking supply, quality and regulatory obligations across many partners, Sirion fits well, at enterprise cost and implementation effort. Who it suits best: large organisations with heavy obligation and supplier management. ### Icertis Icertis is an enterprise CLM leader with deep configurability and broad integrations, used widely in life sciences for complex supplier and partner contracts. For a very large multinational operation, it fits better than a lighter tool, with a longer implementation. Who it suits best: large enterprises standardising global contract processes. ### SpotDraft SpotDraft is an India-origin CLM strong in workflow automation and approvals. For a mid-sized life-sciences company that needs routing and a searchable repository more than specialised drafting, it is a practical fit. Pricing is quote-based. Who it suits best: mid-market teams automating standard contract workflows. ## How to choose Start from complexity and scale. If the pain is drafting and reviewing specialised, clause-heavy agreements correctly under India law, Adira's structured drafting plus per-clause review and public per-seat pricing fit best, and its no-training stance suits confidential research paper. If you are a large organisation whose main problem is tracking regulatory, quality and supply obligations across many partners, Sirion or Icertis are the enterprise answers, at higher cost and effort. If you need workflow automation and a repository at mid-market scale, SpotDraft is pragmatic. Use free trials and test on your real CRO and quality agreements first. ## Common mistakes pharma and life-sciences teams make with contract software - Flattening structured agreements into plain text. CRO, CDA and MTA paper depends on precise links between confidentiality, IP-ownership and indemnity clauses; a tool that treats a contract as flat text loses those dependencies and makes edits risky.
• Uploading confidential research to a tool that trains on it. Research and pre-clinical terms are sensitive, so a vendor that learns from your corpus is a genuine concern.
• No obligation tracking for regulatory and quality duties. Pharmacovigilance reporting and quality-agreement commitments carry hard dates; a signed-and-forgotten contract becomes a compliance gap.
• Picking an enterprise platform for a drafting problem. If the pain is getting specialised agreements right, a heavy obligation-management platform solves the wrong problem. ## Questions to ask before you choose Ask whether the tool models contracts as a structured clause tree so dependencies between confidentiality, IP and indemnity stay intact. Ask, in writing, whether the vendor trains on your corpus and what the encryption, access and data-residency terms are. Ask whether regulatory and quality obligations become dated, trackable items. Ask whether the tool flags missing clauses, such as an absent publication or indemnity term. Ask whether pricing is per seat or quote-only. And separate the drafting problem from the obligation-tracking problem, because different tools lead on each. ## Where Adira fits, and where it does not Adira is the strongest fit when the work is drafting and reviewing specialised, clause-heavy agreements such as CRO, CDA, MTA and quality contracts correctly under India law, with a no-training privacy stance for confidential research. It is honestly not the first choice if your dominant need is tracking regulatory, quality and supply obligations across many partners over years, where Sirion and Icertis are built for that post-signature work at enterprise scale. Match the tool to whether your real bottleneck is drafting precision or long-run obligation management, and test each one on your own research and quality paper. ## Bottom line For a pharma or life-sciences company in India, the best tool drafts specialised agreements precisely, flags indemnity, IP and confidentiality risk, and tracks regulatory and quality obligations. Adira fits the drafting and review side well, with Claude-powered structured drafting, per-clause risk grading, a no-training privacy stance and rare public per-seat pricing; Sirion and Icertis suit very large obligation-management needs. See Adira, and weigh it against Sirion, Icertis and SpotDraft on your complexity and scale. This is general information, not legal advice; confirm regulatory obligations with a qualified adviser.